Loading clinical trials...
Loading clinical trials...
The Activity of Indoleamine 2,3-dioxygenase in Patients With Chronic Lymphocytic Leukemia (CLL)
Conditions
Locations
1
Finland
Tampere university Hospital
Tampere, Finland
Start Date
February 1, 2010
Primary Completion Date
December 1, 2010
Completion Date
December 1, 2010
Last Updated
April 19, 2024
NCT06859424
NCT06043011
NCT06528301
NCT02863692
NCT05168930
NCT06916767
Lead Sponsor
Tampere University Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions